Literature DB >> 10452590

Prostatic growth rate determined from MRI data: age-related longitudinal changes.

A M Williams1, I Simon, P K Landis, C Moser, W Christens-Barry, H B Carter, E J Metter, A W Partin.   

Abstract

Men with prostatic enlargement are at highest risk of developing symptomatic lower urinary tract symptoms (LUTS) and related outcomes, such as acute urinary retention. The study of prostatic growth rate can identify the age range at which prostate growth peaks. Evaluation of the natural course of prostate growth requires repeated intraindividual volume measurements at time intervals sufficient to document growth. Our objective was to examine age-stratified prostate growth rates from men taking part in a longitudinal study of aging using magnetic resonance imaging (MRI) of the prostate. Sixty-four men (ages 30-71 years) enrolled in the Baltimore Longitudinal Study of Aging (BLSA) who had T2 pelvic MRIs taken approximately every 2 years were studied. Men were age stratified into four groups: <45, 45-55, 56-65, and >65 years old. Whole prostate and central gland (anatomically referred to as the transition zone) volumes were determined from the MRI images by a semi-automated image analysis program. Peripheral gland volumes were calculated as the difference between whole prostate and central gland volumes. Growth rates (cc per year) were calculated as change in volume divided by the time interval. On the basis of measurements from the T2 images (n = 128), we observed a linear trend between prostate volume and age. The overall prostate growth rate was 2.36 +/- 3.52 cc per year. Age-stratified growth rates revealed that prostate growth increased with age, peaked at 4.15 +/- 4.98 cc/year for the 56-65-year-old age group and then declined rapidly for the older-aged men. The central gland growth rates followed a trend similar to total prostate volume. These data suggest that there is an age-related increase in prostate growth rate that peaks in men ages 56-65 and then declines. Identification of this trend in prostate growth may aid physicians in targeting men for early diagnosis of LUTS and for possible early intervention. Future studies with a larger sample size are necessary to substantiate these findings.

Entities:  

Mesh:

Year:  1999        PMID: 10452590

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  20 in total

1.  Prostate volume growth rate changes over time: Results from men 18 to 92 years old in a longitudinal community-based study.

Authors:  Si-Hui Li; Qun-Fang Yang; Pei-Yuan Zuo; Yu-Wei Liu; Yu-Hua Liao; Cheng-Yun Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-12-07

2.  MRI to predict prostate growth and development in children, adolescents and young adults.

Authors:  Jing Ren; Huijia Liu; He Wang; Didi Wen; Xufang Huang; Fang Ren; Yi Huan
Journal:  Eur Radiol       Date:  2014-08-06       Impact factor: 5.315

Review 3.  Use of 5alpha-reductase inhibitors to prevent benign prostatic hyperplasia disease.

Authors:  Leonard S Marks
Journal:  Curr Urol Rep       Date:  2006-07       Impact factor: 3.092

4.  Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): a cross-sectional study in over 500 patients.

Authors:  Baris Turkbey; Robert Huang; Srinivas Vourganti; Hari Trivedi; Marcelino Bernardo; Pingkun Yan; Compton Benjamin; Peter A Pinto; Peter L Choyke
Journal:  BJU Int       Date:  2012-09-14       Impact factor: 5.588

5.  Typology of intravesical prostatic protrusions, or so-called median lobes, in middle-aged and older men.

Authors:  Marie Audouin; Alexis Girshovich; Olivier Cussenot; Raphaele Renard-Penna
Journal:  Surg Radiol Anat       Date:  2018-03-13       Impact factor: 1.246

6.  Computer simulations suggest that prostate enlargement due to benign prostatic hyperplasia mechanically impedes prostate cancer growth.

Authors:  Guillermo Lorenzo; Thomas J R Hughes; Pablo Dominguez-Frojan; Alessandro Reali; Hector Gomez
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-07       Impact factor: 11.205

7.  Relationship between age and prostate size.

Authors:  Shi-Jun Zhang; Hai-Ning Qian; Yan Zhao; Kai Sun; Hui-Qing Wang; Guo-Qing Liang; Feng-Hua Li; Zheng Li
Journal:  Asian J Androl       Date:  2012-12-10       Impact factor: 3.285

8.  Should prostate specific antigen be adjusted for body mass index? Data from the Baltimore Longitudinal Study of Aging.

Authors:  Stacy Loeb; H Ballentine Carter; Edward M Schaeffer; Luigi Ferrucci; Anna Kettermann; E Jeffrey Metter
Journal:  J Urol       Date:  2009-12       Impact factor: 7.450

9.  Can prostatic arterial embolisation (PAE) reduce the volume of the peripheral zone? MRI evaluation of zonal anatomy and infarction after PAE.

Authors:  Yen-Ting Lin; Grégory Amouyal; Jean-Michel Correas; Héléna Pereira; Olivier Pellerin; Costantino Del Giudice; Carole Déan; Nicolas Thiounn; Marc Sapoval
Journal:  Eur Radiol       Date:  2016-01-06       Impact factor: 5.315

10.  Does prostate growth confound prostate specific antigen velocity? Data from the Baltimore longitudinal study of aging.

Authors:  Stacy Loeb; Anna Kettermann; H Ballentine Carter; Luigi Ferrucci; E Jeffrey Metter; Patrick C Walsh
Journal:  J Urol       Date:  2008-08-15       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.